Simplex Trading, LLC Graphite Bio, Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$2.24 - $2.66 $264 - $313	-118 Reduced 63.44%	68 $0
Q3 2023 Nov 01, 2023	BUY	$2.18 - $2.77 $405 - $515	186 New	186 $0
Q4 2022 Feb 02, 2023	SELL	$2.82 - $3.59 $98,110 - $124,899	-34,791 Reduced 91.23%	3,346 $11,000
Q3 2022 Nov 04, 2022	SELL	$2.82 - $4.24 $87,284 - $131,236	-30,952 Reduced 44.8%	38,137 $120,000
Q2 2022 Aug 03, 2022	BUY	$2.14 - $5.23 $147,850 - $361,335	69,089 New	69,089 $189,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.